1-4 of 4
Authors: Mohammad Jahanzeb
Save search
Sort by
Journal Article

Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States

PDF
Mohammad Jahanzeb and others
The Oncologist, Volume 27, Issue 9, September 2022, Pages 790–798, https://doi.org/10.1093/oncolo/oyac116
Published: 04 July 2022
Journal Article

Real‐World Treatment Patterns and Progression‐Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+ Non‐Small Cell Lung Cancer

PDF
Mohammad Jahanzeb and others
The Oncologist, Volume 25, Issue 10, October 2020, Pages 867–877, https://doi.org/10.1634/theoncologist.2020-0011
Published: 23 July 2020
Journal Article

De Novo Versus Recurrent HER2‐Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry

PDF
Debu Tripathy and others
The Oncologist, Volume 25, Issue 2, February 2020, Pages e214–e222, https://doi.org/10.1634/theoncologist.2019-0446
Published: 14 October 2019
Journal Article

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First-Line Therapy in Patients with HER2+ Metastatic Breast Cancer

PDF
Mohammad Jahanzeb and others
The Oncologist, Volume 7, Issue 5, October 2002, Pages 410–417, https://doi.org/10.1634/theoncologist.7-5-410
Published: 01 October 2002